Daratumumab Supplier-Buyer Network — Trade Flow Analysis

Name: Daratumumab Supplier-Buyer Trade Network Dataset — 36+ Indian Exporters, 10+ Importers, 23+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Daratumumab supplier network, Daratumumab buyers, pharmaceutical export India, Daratumumab trade data

TransData Nexus

Daratumumab

India Pharmaceutical Trade Intelligence

$1.3M36 Suppliers23 CountriesHS 30049099

ExportsIndia → BRAZIL45.9%India → CAYMAN ISLANDS9.4%

ImportsSWITZERLAND → India$344.4M BELGIUM → India$4.9M

#1 Supplier: VAMA LIFECARE #1 Buyer: AS PER

Who Supplies Daratumumab? Top Manufacturers & Buyers 2026 — VAMA LIFECARE PRIVATE LIMITED Leads | TransData Nexus | TransData Nexus

1VAMA LIFECARE PRIVATE LIMITED

VAMA LIFECARE PRIVATE LIMITED is the first-largest Daratumumab exporter from India, with a market share of 20.1% and a total export value of $268.2K across 29 shipments. Their average shipment value of $9.2K is above the market average of $6.4K, suggesting premium or bulk contract pricing.

VAMA LIFECARE PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• AS PER INVOICE BRAZIL — $93.8K across 10 shipments (35.0% of this supplier's total exports)

• AS PER INVOICE AS — $74.3K across 8 shipments (27.7% of this supplier's total exports)

• EXP CODE — $69.0K across 7 shipments (25.7% of this supplier's total exports)

• AS PER INVOICE — $21.8K across 2 shipments (8.1% of this supplier's total exports)

• TO THE — $9.4K across 1 shipments (3.5% of this supplier's total exports)

Key Insight: VAMA LIFECARE PRIVATE LIMITED's per-shipment value of $9.2K is 45% above the market average of $6.4K, consistent with large-order contracts or value-added formulations.

2NIVIRA EXPORTS

NIVIRA EXPORTS is the second-largest Daratumumab exporter from India, with a market share of 14.4% and a total export value of $192.9K across 33 shipments. Their average shipment value of $5.8K is below the market average of $6.4K, reflecting a high-volume, competitive pricing strategy.

NIVIRA EXPORTS serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• TO THE CONCERN PERSON — $72.5K across 12 shipments (37.6% of this supplier's total exports)

• MARIA MARIANA DA SILVA CPF N — $53.8K across 9 shipments (27.9% of this supplier's total exports)

• JOAO DE SOUZA MARTINS — $29.9K across 5 shipments (15.5% of this supplier's total exports)

• GENILSON FRANCISCO DE SANTANA — $22.8K across 4 shipments (11.8% of this supplier's total exports)

• AVANY TAVARES DE — $13.9K across 2 shipments (7.2% of this supplier's total exports)

Key Insight: NIVIRA EXPORTS operates with high shipment frequency (33 shipments) at a per-shipment value of $5.8K, indicating a broad distribution network with many smaller, regular orders.

3M. CARE

M. CARE is the third-largest Daratumumab exporter from India, with a market share of 7.6% and a total export value of $102.1K across 6 shipments. Their average shipment value of $17.0K is above the market average of $6.4K, suggesting premium or bulk contract pricing.

M. CARE serves 1 named buyer in our database. TO THE ORDER is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• TO THE ORDER — $102.1K across 6 shipments (100.0% of this supplier's total exports)

Key Insight: M. CARE's per-shipment value of $17.0K is 166% above the market average of $6.4K, consistent with large-order contracts or value-added formulations.

4DOSHI MEDICARE PRIVATE LIMITED

DOSHI MEDICARE PRIVATE LIMITED is the fourth-largest Daratumumab exporter from India, with a market share of 7.4% and a total export value of $98.7K across 23 shipments. Their average shipment value of $4.3K is below the market average of $6.4K, reflecting a high-volume, competitive pricing strategy.

DOSHI MEDICARE PRIVATE LIMITED serves 1 named buyer in our database. TO THE ORDER OF is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• TO THE ORDER OF — $98.7K across 23 shipments (100.0% of this supplier's total exports)

Key Insight: DOSHI MEDICARE PRIVATE LIMITED operates with high shipment frequency (23 shipments) at a per-shipment value of $4.3K, indicating a broad distribution network with many smaller, regular orders.

53S PHARMACEUTICALS INDIA PRIVATE LIMITED

3S PHARMACEUTICALS INDIA PRIVATE LIMITED is the fifth-largest Daratumumab exporter from India, with a market share of 4.9% and a total export value of $64.9K across 9 shipments. Their average shipment value of $7.2K is above the market average of $6.4K, suggesting premium or bulk contract pricing.

3S PHARMACEUTICALS INDIA PRIVATE LIMITED serves 2 named buyers in our database. FOR THE ORDER OF is the dominant customer, accounting for 94.2% of this supplier's tracked business. Top customers include:

• FOR THE ORDER OF — $61.2K across 8 shipments (94.2% of this supplier's total exports)

• FOR THE ORDER OF RIC — $3.7K across 1 shipments (5.8% of this supplier's total exports)

Key Insight: 3S PHARMACEUTICALS INDIA PRIVATE LIMITED's per-shipment value of $7.2K is 13% above the market average of $6.4K, consistent with large-order contracts or value-added formulations.

6VEA IMPEX (I) PRIVATE LIMITED

VEA IMPEX (I) PRIVATE LIMITED is the fifth-largest Daratumumab exporter from India, with a market share of 3.5% and a total export value of $46.8K across 9 shipments. Their average shipment value of $5.2K is below the market average of $6.4K, reflecting a high-volume, competitive pricing strategy.

VEA IMPEX (I) PRIVATE LIMITED serves 2 named buyers in our database. TO THE ORDER OF INVO is the dominant customer, accounting for 65.1% of this supplier's tracked business. Top customers include:

• TO THE ORDER OF INVO — $30.5K across 6 shipments (65.1% of this supplier's total exports)

• TO THE ORDER OF INVO — $16.3K across 3 shipments (34.9% of this supplier's total exports)

Key Insight: VEA IMPEX (I) PRIVATE LIMITED operates with high shipment frequency (9 shipments) at a per-shipment value of $5.2K, indicating a broad distribution network with many smaller, regular orders.

1Brazil

Brazil ranks as the first-largest destination for Daratumumab imports from India, with a total trade value of $613.3K across 56 shipments — representing a 45.9% share of all Daratumumab exports. The average shipment value of $11.0K is above the global average of $6.4K, indicating high-value procurement contracts or branded formulations. This market is served by 8 tracked buyers.

Named Daratumumab importers in Brazil: AS PER INVOICE BRAZIL is the largest buyer, accounting for 15.3% ($93.8K) of this market's total imports.

• AS PER INVOICE BRAZIL — $93.8K (15.3% of Brazil's total)

• AS PER INVOICE AS — $74.3K (12.1% of Brazil's total)

• TO THE CONCERN PERSON — $72.5K (11.8% of Brazil's total)

Key Insight: Brazil's per-shipment average of $11.0K (71% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Brazil is a key market for Daratumumab imports from India.

Primary Market

Secondary Market

2Cayman Islands

Cayman Islands ranks as the second-largest destination for Daratumumab imports from India, with a total trade value of $125.7K across 0 shipments — representing a 9.4% share of all Daratumumab exports. The average shipment value of $125.7K is above the global average of $6.4K, indicating high-value procurement contracts or branded formulations.

Key Insight: Cayman Islands's per-shipment average of $125.7K (1865% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Cayman Islands is a key market for Daratumumab imports from India.

Primary Market

Secondary Market

3Oman

Oman ranks as the third-largest destination for Daratumumab imports from India, with a total trade value of $102.1K across 0 shipments — representing a 7.6% share of all Daratumumab exports. The average shipment value of $102.1K is above the global average of $6.4K, indicating high-value procurement contracts or branded formulations.

Key Insight: Oman's per-shipment average of $102.1K (1498% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Oman is a key market for Daratumumab imports from India.

Primary Market

Secondary Market

4Zimbabwe

Zimbabwe ranks as the fourth-largest destination for Daratumumab imports from India, with a total trade value of $60.7K across 0 shipments — representing a 4.5% share of all Daratumumab exports. The average shipment value of $60.7K is above the global average of $6.4K, indicating high-value procurement contracts or branded formulations.

Key Insight: Zimbabwe's per-shipment average of $60.7K (849% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Zimbabwe is a key market for Daratumumab imports from India.

Primary Market

Secondary Market

5Georgia

Georgia ranks as the fifth-largest destination for Daratumumab imports from India, with a total trade value of $59.1K across 8 shipments — representing a 4.4% share of all Daratumumab exports. The average shipment value of $7.4K is above the global average of $6.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Daratumumab importers in Georgia: MERMISI LLC is the largest buyer, accounting for 91.4% ($54.0K) of this market's total imports.

• MERMISI LLC — $54.0K (91.4% of Georgia's total)

Key Insight: Georgia's per-shipment average of $7.4K (16% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Georgia is a key market for Daratumumab imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Daratumumab.
2.Flow Mapping: 36 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 209 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 23 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

209 Verified Shipments

36 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Daratumumab

Daratumumab

Who Supplies Daratumumab? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Daratumumab? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Daratumumab Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1VAMA LIFECARE PRIVATE LIMITED

2NIVIRA EXPORTS

3M. CARE

4DOSHI MEDICARE PRIVATE LIMITED

53S PHARMACEUTICALS INDIA PRIVATE LIMITED

6VEA IMPEX (I) PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Daratumumab Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Daratumumab Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Brazil

2Cayman Islands

3Oman

4Zimbabwe

5Georgia

People Also Ask — Daratumumab Supplier & Trade Network

Daratumumab Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology